Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments This study covers the world outlook for alpha-1 antitrypsin deficiency treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Infertility Drugs
The 2025-2030 World Outlook for Infertility Drugs This study covers the world outlook for infertility drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Primary Focal Segmental Glomerulosclerosis
The 2025-2030 World Outlook for Primary Focal Segmental Glomerulosclerosis This study covers the world outlook for primary focal segmental glomerulosclerosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Myasthenia Gravis Drugs
The 2025-2030 World Outlook for Myasthenia Gravis Drugs This study covers the world outlook for myasthenia gravis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs This study covers the world outlook for mutation-suppression Duchenne muscular dystrophy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Critical Care Therapeutics
The 2025-2030 World Outlook for Critical Care Therapeutics This study covers the world outlook for critical care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Epilepsy Therapeutics
The 2025-2030 World Outlook for Epilepsy Therapeutics This study covers the world outlook for epilepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Rare Endocrine Disease Treatments
The 2025-2030 World Outlook for Rare Endocrine Disease Treatments This study covers the world outlook for rare endocrine disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics
The 2025-2030 World Outlook for Dermatophytic Onychomycosis Therapeutics This study covers the world outlook for dermatophytic onychomycosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments
The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments This study covers the world outlook for interleukin blockers for psoriasis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Epilepsy Treatments
The 2025-2030 World Outlook for Epilepsy Treatments This study covers the world outlook for epilepsy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Veterinary Therapeutics
The 2025-2030 World Outlook for Veterinary Therapeutics This study covers the world outlook for veterinary therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Crohn's Disease Therapeutics
The 2025-2030 World Outlook for Crohn's Disease Therapeutics This study covers the world outlook for Crohn's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Rabies Treatments
The 2025-2030 World Outlook for Rabies Treatments This study covers the world outlook for rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics This study covers the world outlook for guillain-Barre syndrome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Mouth Ulcer Drugs
The 2025-2030 World Outlook for Mouth Ulcer Drugs This study covers the world outlook for mouth ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema Treatments
The 2025-2030 World Outlook for Hereditary Angioedema Treatments This study covers the world outlook for hereditary angioedema treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Cardiovascular Therapeutics
The 2025-2030 World Outlook for Cardiovascular Therapeutics This study covers the world outlook for cardiovascular therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for CNS Therapeutics
The 2025-2030 World Outlook for CNS Therapeutics This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Alopecia Drugs
The 2025-2030 World Outlook for Alopecia Drugs This study covers the world outlook for alopecia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for HIV Therapeutics
The 2025-2030 World Outlook for HIV Therapeutics This study covers the world outlook for HIV therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
Research Assistance
